Skip to content
  • About Ventures
  • Strategy
  • Portfolio
  • Our Team
  • News & Insights
  • Get Funded
  • Deeptech Nation
Scroll down to content

Investment Partner

PhD in Biochemistry

Myoung-Ok Kwon

Office
Zurich, Switzerland
Focus
Digital Health

Send Mail

Myoung has 17 years of experience in healthcare investment and pharma research. Prior to joining Swisscom Ventures in June 2021, she managed a biotech venture fund and two public equity funds focusing on small- and mid-cap biotech companies in the field of therapeutics, diagnostics and medical device. Previously, she worked at Novartis and was responsible for research strategy & planning and portfolio review.

Deals of Myoung-Ok Kwon

Neo Medical

Leader in Value Based Care Technology for Spine

Medimaps

Technology for multiple medical applications

Nanolive

Hardware and software solution for cell research

Newsroom

Press Release
05.04.2022

Nanolive SA Announces Initial Closing of Series C-1 Round

Nanolive successfully completed the initial closing of US$20 million in the Series C-1 equity financing round of investment.

Press Release
21.02.2022

Neo Medical closes Swisscom Ventures-lead USD $20.6M financing round

Proceeds to accelerate the commercial deployment of Neo Medical AI-driven ADVISEā„¢ augmented reality platform for spinal surgery

Insight
10.01.2022

Join us on January 20th for the Swisscom Ventures Romandie Community event.

Press Release
02.12.2021

Medimaps raises $20M for AI bone health software

The $20 million financing round was supported by a Swiss VC syndicate including Swisscom Ventures.

Get in touch.

  • Facebook Swisscom
  • Twitter Swisscom
  • LinkedIn Swisscom
  • Our Startup Jobs
  • swisscom.ch
  • Legal Notice
  • Privacy Policy

© Swisscom 2023